生物活性 | |||
---|---|---|---|
描述 | JNJ-42226314 is a competitive, highly selective, and reversible non-covalent monoacylglycerol lipase (MAGL) inhibitor. It exhibits dose-dependent augmentation of the major endocannabinoid 2-arachidonoylglycerol (2-AG) and demonstrates efficacy in neuropathic and inflammatory pain models[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.04mL 0.41mL 0.20mL |
10.21mL 2.04mL 1.02mL |
20.43mL 4.09mL 2.04mL |
参考文献 |
---|